COVID-19's Impact on Cancer Data

The COVID-19 pandemic has had a significant impact on all facets of cancer care, including a reduction in screening exams, delaying diagnoses and treatment as well as halting clinical trials. As care providers work tirelessly to ensure that patients continue to receive essential treatment while minimizing exposure to the virus, what can we expect to learn from the data? In this episode, Dr. Serban Negoita, Chief of the Data Quality. Analysis and Interpretation Branch at the National Cancer Institute, Dr. Oguzhan Alagoz, Breast CISNET modeler from University of Wisconsin-Madison, and Karen Schmidt, CTR, vice president of CHAMPS Oncology, will discuss what we can learn from this pandemic, the long term effects on survival rates and the implications on cancer statistics.